WELICEF 1GM contains Ceftriaxone 1 g in an injectable presentation and is positioned for the treatment of selected susceptible bacterial infections requiring parenteral therapy. Its broad-spectrum cephalosporin profile, established clinical familiarity and convenient hospital application make it an important core product for physician and institutional markets. A strong and commercially relevant PCD Pharma Injectable Antibiotic brand for a comprehensive anti-infective portfolio.
A wide range of susceptible bacterial infections requiring injectable cephalosporin therapy.
No.
Its broad activity, long duration of action and convenient injectable administration make it useful across multiple clinical settings.
Administer only under qualified medical supervision and after appropriate evaluation of allergy history and infection type. Use according to local antibiotic policy and susceptibility information where available. Monitor clinical response and relevant organ function when indicated. Therapy should be reviewed once culture results and clinical improvement are available to support responsible antibiotic use.
Diarrhea, nausea, vomiting, abdominal discomfort, rash, headache and injection-site discomfort may occur. Allergic reactions can occur in patients with beta-lactam hypersensitivity. Some patients may develop biliary sludge or changes in liver-related laboratory values. Rare but serious reactions require urgent medical attention. Persistent diarrhea, severe rash, facial swelling, breathing difficulty or other unusual symptoms should be promptly assessed.
WELICEF 1GM: Ceftriaxone is a third-generation cephalosporin that exerts bactericidal activity by binding to bacterial penicillin-binding proteins and inhibiting the final stages of cell-wall synthesis. This disrupts bacterial structural integrity and results in death of susceptible organisms. Its broad spectrum and prolonged activity support once-daily administration in many appropriate clinical situations, making it widely useful in hospital and physician-managed infectious disease care.
